Direct Effects of Glucagon-Like Peptide-1 Receptor Ligands on Myocardial Function in Isolated Hearts from Streptozotocin-Induced Diabetic Rats
Abstract Purpose Glucagon-like peptide-1 (GLP-1) receptor ligands are widely used for the treatment of type 2 diabetes mellitus and obesity and have demonstrated cardioprotective effects beyond glycemic control. This study investigated the direct effects of GLP-1 receptor ligands and the dipeptidyl peptidase-4 inhibitor sitagliptin on myocardial function in isolated hearts from streptozotocin-induced diabetic rats. Methods Diabetes was induced in male Wistar rats by a single intraperitoneal injection of streptozotocin (50 mg/kg). Hearts from control and diabetic rats were retrogradely perfused for 30 min using a Langendorff system with GLP-1 (7–36), GLP-1 (9–36), exendin-4 (1–39), sitagliptin, glimepiride, pioglitazone, or metformin. Cardiac functional parameters, plasma total and active GLP-1 concentrations and serum total antioxidant status (TAS), total oxidant status (TOS), total sulfhydryl groups (TSG), advanced oxidation protein products (AOPP), and ischemia-modified albumin (IMA) were assessed. Results Diabetic hearts exhibited significantly lower heart rates and impaired left ventricular contractility and relaxation, indicated by reduced left ventricular + dP/dt max and -dP/dt min values, compared with controls. GLP-1 (7–36), GLP-1 (9–36), and exendin-4 (1–39) partially improved contractility and relaxation. Compared with controls, diabetic rats exhibited significantly higher plasma total and active GLP-1 concentrations, increased serum TOS and AOPP levels, and reduced TSG levels, whereas serum TAS and IMA levels remained unchanged. Conclusion These findings suggest that GLP-1 receptor ligands partially improve myocardial contractility and relaxation in isolated hearts from streptozotocin-induced diabetic rats, although the mechanisms underlying these effects remain to be elucidated.
Authors
- Gül Özbey (ORCID: https://orcid.org/0000-0002-3616-0052)
- Cahit Nacıtarhan (ORCID: https://orcid.org/0000-0003-2601-4921)
- Sebahat Özdem (ORCID: https://orcid.org/0000-0002-0619-1405)
- Zinnet Şevval Aksoyalp (ORCID: https://orcid.org/0000-0002-7822-3154)
- Esra Akcabag (ORCID: https://orcid.org/0000-0002-6238-8173)
- Feride Öner
- Arda Taşatargil (ORCID: https://orcid.org/0000-0002-1077-3029)
- Sadi S. Özdem (ORCID: https://orcid.org/0000-0003-4325-5209)
- Zeliha Bayram
Institutions
- Akdeniz University (TR)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-13
- DOI
- https://doi.org/10.21203/rs.3.rs-11561270/v1
- Primary Topic
- Diabetes Treatment and Management
- Type
- preprint
Funders
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu